Related references
Note: Only part of the references are listed.Covid-19 induced superimposed bacterial infection
Mohamed A. Hendaus et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient
Enrico Bentivegna et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection
Enrico Bentivegna et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2021)
Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research
Hiroshi Nakase et al.
DIGESTION (2021)
Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?
Michelangelo Luciani et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study
Enrico Bentivegna et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
SARS-CoV-2-Indigenous Microbiota Nexus: Does Gut Microbiota Contribute to Inflammation and Disease Severity in COVID-19?
Indranil Chattopadhyay et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
The interplay of SARS-CoV-2 and Clostridioides difficile infection
Sahil Khanna et al.
FUTURE MICROBIOLOGY (2021)
The human microbiome and COVID-19: A systematic review
Shinya Yamamoto et al.
PLOS ONE (2021)
Repurposing of antibiotics for clinical management of COVID-19: a narrative review
Abdourahamane Yacouba et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2021)
SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
Mark C. Howell et al.
CANCERS (2021)
The Vitamin D, IL-6 and the eGFR Markers a Possible Way to Elucidate the Lung-Heart-Kidney Cross-Talk in COVID-19 Disease: A Foregone Conclusion
Mario Giosue Balzanelli et al.
MICROORGANISMS (2021)
Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients
Philipp K. Buehler et al.
CELL REPORTS MEDICINE (2021)
Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study
Laila Carolina Abu Esba et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
From Nursery to Nursing Home: Emerging Concepts in Clostridioides difficile Pathogenesis
Alexander B. Smith et al.
INFECTION AND IMMUNITY (2020)
Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China
Weier Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Complex Scenario of Nonsteroidal Anti-inflammatory Drugs Induced Prostaglandin E2 Production and Gut Microbiota Alteration in Clostridium difficile-Infected Mice
Maryam Noori et al.
MBIO (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics
Martina Rekatsina et al.
ADVANCES IN THERAPY (2020)
Why does COVID-19 disproportionately affect older people?
Amber L. Mueller et al.
AGING-US (2020)
COVID-19 and mycoplasma pneumoniae coinfection
Bingwen Eugene Fan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Bo Shen et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
Mahmoud Gheblawi et al.
CIRCULATION RESEARCH (2020)
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
Timothy M. Rawson et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19: don't neglect antimicrobial stewardship principles!
B. D. Huttner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Tao Zuo et al.
GASTROENTEROLOGY (2020)
COVID-19 and immunomodulation in IBD
Markus F. Neurath
GUT (2020)
Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process
Hao Zhang et al.
GUT (2020)
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wenling Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of deaths in the novel coronavirus epidemic in China
Char Leung
REVIEWS IN MEDICAL VIROLOGY (2020)
The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
Qiang Ding et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
Dandan Wu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
Joelle Micallef et al.
THERAPIE (2020)
The New Challenge of Geriatrics: Saving Frail Older People from the SARS-CoV-2 Pandemic Infection
F. Landi et al.
JOURNAL OF NUTRITION HEALTH & AGING (2020)
Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths
William B. Grant et al.
NUTRIENTS (2020)
Non-steroidal anti-inflammatory drugs and covid-19
Paul Little
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease Insights From Cardiovascular Aging Science
Majd AlGhatrif et al.
JAMA CARDIOLOGY (2020)
COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients
Patrizia Spigaglia
ANAEROBE (2020)
Gastrointestinal Symptoms and Outcomes in Hospitalized Coronavirus Disease 2019 Patients
Preethi Ramachandran et al.
DIGESTIVE DISEASES (2020)
Tackling antimicrobial resistance in the COVID-19 pandemic
Haileyesus Getahun et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
NSAID-Gut Microbiota Interactions
Damian Maseda et al.
FRONTIERS IN PHARMACOLOGY (2020)
Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period
Marietta Iacucci et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Risk Factors for PrimaryClostridium difficileInfection; Results From the Observational Study of Risk Factors forClostridium difficileInfection in Hospitalized Patients With Infective Diarrhea (ORCHID)
Kerrie Davies et al.
FRONTIERS IN PUBLIC HEALTH (2020)
COVID-19 is an emergent disease of aging
Didac Santesmasses et al.
AGING CELL (2020)
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth J. Williamson et al.
NATURE (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses (vol 41, pg 355, 2020)
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
The immune system and COVID-19: Friend or foe?
Fereshteh Yazdanpanah et al.
LIFE SCIENCES (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
Should We Be Worried About Clostridioides difficile During the SARS-CoV2 Pandemic?
Eliane de Oliveira Ferreira et al.
FRONTIERS IN MICROBIOLOGY (2020)
The Immune Response and Immunopathology of COVID-19
Esmaeil Mortaz et al.
FRONTIERS IN IMMUNOLOGY (2020)
The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens
Liangwei Duan et al.
FRONTIERS IN IMMUNOLOGY (2020)
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
Courtney J. Mycroft-West et al.
THROMBOSIS AND HAEMOSTASIS (2020)
The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid)
Guido Granata et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19)
Yixin Liew et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
Indwiani Astuti et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
The gut microbiome's role in the development, maintenance, and outcomes of sepsis
Max W. Adelman et al.
CRITICAL CARE (2020)
Clostridium difficile toxins or infection induce upregulation of adenosine receptors and IL-6 with early pro-inflammatory and late anti-inflammatory pattern
D. A. Foschetti et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2020)
Age-Related Morbidity and Mortality among Patients with COVID-19
Seung-Ji Kang et al.
INFECTION AND CHEMOTHERAPY (2020)
Clostridioides difficileribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
Masoumeh Azimirad et al.
EMERGING MICROBES & INFECTIONS (2020)
COVID-19: Therapeutics and Their Toxicities
Michael A. Chary et al.
JOURNAL OF MEDICAL TOXICOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis
Haneul Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020
Avnish Sandhu et al.
EMERGING INFECTIOUS DISEASES (2020)
Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection
Mahmoud M. Saleh et al.
CELL HOST & MICROBE (2019)
The Commensal Microbiota and Viral Infection: A Comprehensive Review
Na Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
Age-Related Dysfunctions: Evidence and Relationship with Some Risk Factors and Protective Drugs
G. Libertini et al.
BIOCHEMISTRY-MOSCOW (2019)
Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate Clostridium difficile Colitis while Dysregulating the Inflammatory Response
Damian Maseda et al.
MBIO (2019)
New insights into transmission of Clostridium difficile infection-narrative review
A. Durovic et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
Julien Kirchgesner et al.
GASTROENTEROLOGY (2018)
Infectious Diseases in Older Adults of Long-Term Care Facilities: Update on Approach to Diagnosis and Management
Robin L. P. Jump et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Disruption of the Gut Ecosystem by Antibiotics
Mi Young Yoon et al.
YONSEI MEDICAL JOURNAL (2018)
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Supakanya Wongrakpanich et al.
AGING AND DISEASE (2018)
Indomethacin increases severity of Clostridium difficile infection in mouse model
Juan Munoz-Miralles et al.
FUTURE MICROBIOLOGY (2018)
Interactions Between Clostridioides difficile and Fecal Microbiota in in Vitro Batch Model: Growth, Sporulation, and Microbiota Changes
Sabina Horvat et al.
FRONTIERS IN MICROBIOLOGY (2018)
Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level
Caner Gunaydin et al.
EURASIAN JOURNAL OF MEDICINE (2018)
Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship
Maria Adriana Cataldo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Clostridium difficile in Older Adults
Curtis J. Donskey
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2017)
Secondary Bacterial Infections Associated with Influenza Pandemics
Denise E. Morris et al.
FRONTIERS IN MICROBIOLOGY (2017)
Risk factors for Clostridium difficile infections-an overview of the evidence base and challenges in data synthesis
Paul Eze et al.
JOURNAL OF GLOBAL HEALTH (2017)
Control of Clostridium difficile Infection by Defined Microbial Communities
James Collins et al.
MICROBIOLOGY SPECTRUM (2017)
Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity
Hua Yu et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage
Koji Otani et al.
DIGESTION (2017)
Mining the Human Gut Microbiota for Immunomodulatory Organisms
Naama Geva-Zatorsky et al.
CELL (2017)
The influence of non-steroidal anti-inflammatory drugs on the gut microbiome
M. A. M. Rogers et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Pseudomembranous colitis
Priya D. Farooq et al.
DM DISEASE-A-MONTH (2015)
Diagnosis and Treatment of Clostridium difficile in Adults A Systematic Review
Natasha Bagdasarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies
Emily K. Calton et al.
PLOS ONE (2015)
Colonization Resistance of the Gut Microbiota against Clostridium difficile
Ana Elena Perez-Cobas et al.
ANTIBIOTICS-BASEL (2015)
Vitamin D in inflammatory diseases
Thea K. Woebke et al.
FRONTIERS IN PHYSIOLOGY (2014)
Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea
Wallace J. Wang et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2014)
Human Monoclonal Antibodies against Clostridium difficile Toxins A and B Inhibit Inflammatory and Histologic Responses to the Toxins in Human Colon and Peripheral Blood Monocytes
Hon Wai y Koon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
Laurence Josset et al.
MBIO (2013)
Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease
Daniel Suissa et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Consequences of Clostridium difficile infection: understanding the healthcare burden
E. Bouza
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1
Yong Zhang et al.
JOURNAL OF IMMUNOLOGY (2012)
Clostridium difficile Toxins: Mediators of Inflammation
Aimee Shen
JOURNAL OF INNATE IMMUNITY (2012)
A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity
Philip G. Conaghan
RHEUMATOLOGY INTERNATIONAL (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
Human Coronaviruses: Insights into Environmental Resistance and Its Influence on the Development of New Antiseptic Strategies
Chloe Geller et al.
VIRUSES-BASEL (2012)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Host and Pathogen Factors for Clostridium difficile Infection and Colonization
Vivian G. Loo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Relationship between age and metabolic disorders in the population of Bali
Ketut Suastika et al.
JOURNAL OF CLINICAL GERONTOLOGY & GERIATRICS (2011)
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection
Angela E. Reeves et al.
GUT MICROBES (2011)
Clostridium difficile toxins:: Mechanism of action and role in disease
DE Voth et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Role of inducible cyclooxygenase and prostaglandins in Clostridium difficile toxin A-induced secretion and inflammation in an animal model
C Alcantara et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Coronavirus spike proteins in viral entry and pathogenesis
TM Gallagher et al.
VIROLOGY (2001)
Share Paper
